| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $18,428,693 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01HD096037 | Cytoplasmic Maturation in Mouse Oocytes | 000 | 5 | NIH | 2/15/2024 | $310,993 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | U01DE028520 | Individualized Assessment and Treatment Program for TMD: Coping as a Mechanism | 000 | 5 | NIH | 2/1/2024 | $568,937 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01AG068860 | Reciprocal Modulation of the Microbiome and Cellular Senescence in Metabolic Dysfunction | 000 | 4 | NIH | 10/30/2023 | $42,531 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | K08NS110929 | Molecular Mechanisms and Treatment of Diffuse Axonal Injury | 002 | 5 | NIH | 2/29/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | K08NS110929 | Molecular Mechanisms and Treatment of Diffuse Axonal Injury | 001 | 5 | NIH | 2/23/2024 | $218,864 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01CA233636 | Targeting sideroflexin 4, a mitochondrial inner membrane protein involved iniron sulfur cluster biogenesis, to enhance the efficacy of DNA-damaging drugs inovarian cancer | 000 | 5 | NIH | 11/3/2023 | $337,635 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01HL150362 | RNA-Binding Proteins in the Regulation of Vascular Inflammation and Immunity | 000 | 4 | NIH | 1/19/2024 | $490,600 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01CA245514 | The selective advantage of mismatch repair loss in colonic stem cells | 000 | 4 | NIH | 2/23/2024 | $400,930 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01AI150919 | The essential role of cyclin-dependent kinase CRK9 in trypanosome pre-mRNA processing | 000 | 4 | NIH | 2/20/2024 | $369,000 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01AI158435 | Structural and mechanistic elucidation of non-canonical inflammasome signaling | 000 | 4 | NIH | 2/16/2024 | $369,000 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01HL153835 | Perinuclear Signaling and Cardiac Hypertrophy | 000 | 4 | NIH | 2/20/2024 | $483,995 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01HD106617 | Impact of Perinatal Pandemic-Related Stress on the Early Caregiving Environment, Infant Functioning, DNA Methylation, and Telomere Length | 001 | 4 | NIH | 3/22/2024 | $528,327 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01NS120556 | Combinatorial function of Foxp1/2/4 in Purkinje cell diversification and cerebellar development | 000 | 4 | NIH | 3/25/2024 | $492,295 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01AR077962 | MicroRNA regulation of osteoblast physiology and glucocorticoid signaling | 000 | 3 | NIH | 10/25/2023 | $387,625 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R35GM128635 | Mechanisms of coordinate gene regulation by transcription factors | 001 | 6 | NIH | 12/21/2023 | $448,875 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01DA047183 | Promoting employment in persons living with HIV/AIDS | 000 | 5 | NIH | 1/19/2024 | $530,970 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R35NS097272 | Sensory pathways for stimulus detection during behavior | 001 | 8 | NIH | 12/7/2023 | $0 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R35NS097272 | Sensory pathways for stimulus detection during behavior | 000 | 8 | NIH | 11/24/2023 | $492,974 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R35GM118140 | Genomic Analysis of Nucleic Acid Transactions | 000 | 9 | NIH | 3/13/2024 | $569,183 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01DE021103 | Modulated release of anti-senescence drugs to stimulate aged bone repair | 000 | 9 | NIH | 1/26/2024 | $454,002 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01MH085927 | Synaptic function of BK channel-interacting proteins | 000 | 13 | NIH | 12/18/2023 | $496,549 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01AR055607 | Notch signaling and Bone Fracture Healing | 000 | 12 | NIH | 1/4/2024 | $494,668 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01NS134604 | Ionically Conductive Polymeric Biomaterials and Grafts for Nerve Regeneration | 000 | 1 | NIH | 12/26/2023 | $430,763 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01AR082440 | Causative mechanisms for keloid formation | 000 | 1 | NIH | 12/20/2023 | $447,738 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01AR084264 | Signaling mechanisms utilized by myostatin and related ligands in skeletal muscle | 000 | 1 | NIH | 3/22/2024 | $785,937 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R03DK135896 | Investigating the Cell Type- and Receptor-Specific Effects of Erythropoietin that Mediate Erythropoiesis and Thrombopoiesis in Primary Human Hematopoietic Progenitor Cells | 000 | 1 | NIH | 12/6/2023 | $124,656 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01NS131661 | Transient Receptor Potential Melastatin 2 (TRPM2) in Ischemic Stroke | 000 | 1 | NIH | 11/30/2023 | $451,949 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01HL172239 | ASCVD risk assessment in T2DM facilitated by novel computational immunology programs | 000 | 1 | NIH | 11/30/2023 | $520,099 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01CA282775 | How RNA binding proteins control effector T cell responses | 000 | 1 | NIH | 3/8/2024 | $474,189 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | F30DE032598 | Molecular Mechanisms of Pseudomonas aeruginosa Antibiotic Persistence in Monocultures and Microbial Communities | 000 | 1 | NIH | 2/9/2024 | $2,500 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R21AG078972 | Epidemiology and Clinical Outcomes of Electroconvulsive Therapy Use in Nursing Home Residents with Dementia | 000 | 2 | NIH | 2/21/2024 | $140,718 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01AI173305 | Impact of Senolytics on Aged Vaccine Responses | 000 | 2 | NIH | 10/30/2023 | $373,875 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R21AI170981 | UBXN1 Regulates Inflammasome Signaling | 000 | 2 | NIH | 1/18/2024 | $224,494 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01DK132059 | Importance of cell-matrix interactions in kidney repair after acute kidney injury | 000 | 2 | NIH | 12/5/2023 | $438,550 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01NS131327 | Role of CD8 T cell-mediated Pathology in Globoid Cell Leukodystrophy | 001 | 2 | NIH | 1/18/2024 | $453,853 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01NS124666 | Serine/Threonine Phosphatases in Neurological Diseases | 000 | 2 | NIH | 12/29/2023 | $454,943 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R21CA279098 | Understanding how the interaction between Lag3 deficiency and hypercholesterolemia impact anti-tumor immunity and cardiovascular disease in a melanoma model | 000 | 2 | NIH | 3/14/2024 | $140,005 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01AR081631 | CGRP-CLR mediated regulation of bone healing | 000 | 2 | NIH | 1/22/2024 | $374,935 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R21AR080642 | A NOTCH2 Mutation Causes Osteogenesis Imperfecta | 000 | 2 | NIH | 1/3/2024 | $197,604 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | F30AG081134 | The role of beta-secretase 1 (BACE1) in modulating excitatory synaptic and circuit function and behavior | 000 | 2 | NIH | 12/28/2023 | $43,907 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01DK134475 | Novel mechanisms of kidney inflammation and fibrosis | 000 | 2 | NIH | 12/13/2023 | $483,172 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R21MH130902 | Role of COP1 in dendritic spines, cognition and stress resilience | 000 | 2 | NIH | 11/1/2023 | $186,985 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R34MH129410 | Enhancing the Capacity of Pediatric Primary Care Providers: A Pilot Trial of Anxiety Action Plan | 000 | 2 | NIH | 1/5/2024 | $229,656 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R25HL152862 | Increasing Research Experiences for Multicultural Students | 000 | 3 | NIH | 12/21/2023 | $71,172 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01AG076642 | Targeting p21-Highly Expressing Cells to Increase Lifespan and Healthspan in Old Age | 000 | 3 | NIH | 2/19/2024 | $431,673 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | F30DK130582 | Dissecting the roles of type 2 diabetes-associated variants and effector genes in islet endoplasmic reticulum stress response | 000 | 3 | NIH | 2/16/2024 | $52,694 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01DK129431 | Role of FGF23 in Bone, Kidney, Blood, Crosstalk in Sickle Cell Disease Mice | 000 | 3 | NIH | 1/26/2024 | $498,828 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01AR077534 | Studies of Osteoclast Lineage in Health and Diseases | 000 | 4 | NIH | 12/8/2023 | $395,255 |
| 2024 | 2024 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | HARTFORD | USA | R01AG066679 | Targeting p21-positive Senescent Cells in vivo for Alleviating Metabolic and Physical Dysfunction | 000 | 5 | NIH | 3/18/2024 | $374,184 |
|